Insulet Corp.
PODD
株式のランク
#2094
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
株価
$141.47
最終同期: 2026-10-19
時価総額
$9.81B
変化（1日）
0.26%
変化（1年）
-56.72%
国
US
取引 Insulet Corp. (PODD)
カテゴリー
Healthcare
Insulet Corp.（PODD）の株式分割履歴
Insulet Corp.株（シンボル：PODD）は合計で0回の株式分割を実施しました。
最新の株式分割はOct 20, 2026に行われました。
Oct 20, 2026より前に購入されたPODD株は、現在0PODD株に相当します。
最新の株式分割はOct 20, 2026に行われました。
Oct 20, 2026より前に購入されたPODD株は、現在0PODD株に相当します。
株式分割一覧
| 年 | 株式分割 | 分割比率 | 累積分割比率 |
|---|---|---|---|
| 提供された日付のデータは十分ではありません。 | |||
類似企業または競合他社の株式分割
| 企業 | 株式分割の回数 | 累積分割比率 | 国 |
|---|---|---|---|
| 9 | x285 |
US
|
|
| 7 | x127 |
IE
|
|
| 9 | x162 |
US
|
|
| 2 | x4 |
US
|
|
| 0 | - |
DE
|
